Skip to content

Science
Pipeline
News
Team

Menu

Science
Pipeline
News
Team

Aardvark Therapeutics, Inc., Announces the Initiation of Enrollment For Three Phase 2 Clinical Trials of Oral ARD-101

Activating Homeostatic Pathways for the Treatment of Disease

Get in Touch to Discover More

Science
Pipeline
News
Team

Science
Pipeline
News
Team

Instagram Facebook Linkedin

© 2022 Aardvark Therapeutics, Inc. All Rights Reserved. Terms of Use | Privacy Policy

Science
Pipeline
News
Team

Science
Pipeline
News
Team

Instagram Facebook Linkedin